Cargando…

Codelivery of HBx-siRNA and Plasmid Encoding IL-12 for Inhibition of Hepatitis B Virus and Reactivation of Antiviral Immunity

Chronic hepatitis B is a critical cause of many serious liver diseases such as hepatocellular carcinoma (HCC). The main challenges in hepatitis B treatment include the rebound of hepatitis B virus (HBV)-related antigen levels after drug withdrawal and the immunosuppression caused by the virus. Herei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mu, Yan, Ren, Xiao-He, Han, Di, Guan, Ying-Ying, Liu, Pei-Ling, Cheng, Si-Xue, Liu, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318813/ https://www.ncbi.nlm.nih.gov/pubmed/35890334 http://dx.doi.org/10.3390/pharmaceutics14071439

Ejemplares similares

Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment
por: Peng, Yuan, et al.
Publicado: (2018)

The Codelivery of siRNA and QDs by pH-Responsive Micelle for Hepatoma Cancer Cells
por: Cao, Zhonglin, et al.
Publicado: (2019)

Liposomal codelivery of an SN38 prodrug and a survivin siRNA for tumor therapy
por: Bi, Ye, et al.
Publicado: (2018)

Dual Targeted Nanoparticles for the Codelivery of Doxorubicin and siRNA Cocktails to Overcome Ovarian Cancer Stem Cells
por: Chen, Li, et al.
Publicado: (2023)

Enhanced apoptosis of ovarian cancer cells via nanocarrier-mediated codelivery of siRNA and doxorubicin
por: Zou, Seyin, et al.
Publicado: (2012)

Involvement of Activation of PKR in HBx-siRNA-Mediated Innate Immune Effects on HBV Inhibition
por: Han, Qiuju, et al.
Publicado: (2011)

Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment
por: Wang, Dandan, et al.
Publicado: (2017)

Intranasal Delivery of Antiviral siRNA
por: Barik, Sailen
Publicado: (2010)

Codelivery of DOX and siRNA by folate-biotin-quaternized starch nanoparticles for promoting synergistic suppression of human lung cancer cells
por: Li, Liangping, et al.
Publicado: (2019)

Codelivery of Doxorubicin and MDR1-siRNA by Mesoporous Silica Nanoparticles-Polymerpolyethylenimine to Improve Oral Squamous Carcinoma Treatment [Corrigendum]
Publicado: (2021)

Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance
por: Haghiralsadat, Fateme, et al.
Publicado: (2018)

Lentiviral-mediated delivery of siRNAs for antiviral therapy
por: Morris, K V, et al.
Publicado: (2006)

Codelivery of GRP78 siRNA and docetaxel via RGD-PEG-DSPE/DOPA/CaP nanoparticles for the treatment of castration-resistant prostate cancer
por: Zhang, Xiangyu, et al.
Publicado: (2019)

Systematic Comparisons of Formulations of Linear Oligolysine Peptides with siRNA and Plasmid DNA
por: Kwok, Albert, et al.
Publicado: (2016)

Multifunctional Lipid-Based Nanoparticles for Codelivery of Anticancer Drugs and siRNA for Treatment of Non-Small Cell Lung Cancer with Different Level of Resistance and EGFR Mutations
por: Majumder, Joydeb, et al.
Publicado: (2021)

Safety and toxicology of the intravenous administration of Ang2-siRNA plasmid chitosan magnetic nanoparticles
por: Shan, Xiuying, et al.
Publicado: (2017)

Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B Virus
por: Ma, Yaojia, et al.
Publicado: (2022)

Optimal design and validation of antiviral siRNA for targeting HIV-1
por: Naito, Yuki, et al.
Publicado: (2007)

Silencing Herpes Simplex Virus Type 1 Capsid Protein Encoding Genes by siRNA: A Promising Antiviral Therapeutic Approach
por: Jin, Fujun, et al.
Publicado: (2014)

Novel targeting of PEGylated liposomes for codelivery of TGF-β1 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study
por: Niu, Ning-Kui, et al.
Publicado: (2015)

Bioinformatics prediction of siRNAs as potential antiviral agents against dengue viruses
por: Villegas-Rosales, Paula M, et al.
Publicado: (2012)

siVirus: web-based antiviral siRNA design software for highly divergent viral sequences
por: Naito, Yuki, et al.
Publicado: (2006)

In Vivo Delivery of Gremlin siRNA Plasmid Reveals Therapeutic Potential against Diabetic Nephropathy by Recovering Bone Morphogenetic Protein-7
por: Zhang, Qingxian, et al.
Publicado: (2010)

Plants Encode a General siRNA Suppressor That Is Induced and Suppressed by Viruses
por: Shamandi, Nahid, et al.
Publicado: (2015)

Fractional Laser-Mediated siRNA Delivery for Mitigating Psoriasis-like Lesions via IL-6 Silencing
por: Lee, Woan-Ruoh, et al.
Publicado: (2019)

Reversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrier
por: Li, Jin-Ming, et al.
Publicado: (2015)

Charge reversible calcium phosphate lipid hybrid nanoparticle for siRNA delivery
por: Cai, Rong-Qiao, et al.
Publicado: (2017)

Selection of predicted siRNA as potential antiviral therapeutic agent against influenza virus
por: Raza, Asif, et al.
Publicado: (2011)

Assorted Processing of Synthetic Trans-Acting siRNAs and Its Activity in Antiviral Resistance
por: Zhao, Mingmin, et al.
Publicado: (2015)

A model system for antiviral siRNA therapeutics using exosome-based delivery
por: Wallen, Margaret, et al.
Publicado: (2022)

Keeping up with the COVID's—Could siRNA‐based antivirals be a part of the answer?
por: Forgham, Helen, et al.
Publicado: (2022)

A model system for antiviral siRNA therapeutics using exosome-based delivery
por: Wallen, Margaret, et al.
Publicado: (2022)

Effect of Chitosan Magnetic Nanoparticles Loaded with Ang2-siRNA Plasmids on the Growth of Melanoma Xenografts in Nude Mice
por: Shan, Xiuying, et al.
Publicado: (2020)

Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA
por: Yingyuad, Peerada, et al.
Publicado: (2014)

Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
por: Berezhnoy, Alexey, et al.
Publicado: (2012)

Where should siRNAs go: applicable organs for siRNA drugs
por: Ahn, Insook, et al.
Publicado: (2023)

Synergistic effects of co-expression plasmid-based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma in vitro and in vivo
por: Liu, Songyang, et al.
Publicado: (2022)

HBx 128–133 Deletion Affecting HBV Mother-to-Child Transmission Weakens HBV Replication via Reducing HBx Level and CP/ENII Transcriptional Activity
por: Song, Yarong, et al.
Publicado: (2022)

Design of Cyclic Peptide-Based Nanospheres and the Delivery of siRNA
por: Ke, Junfeng, et al.
Publicado: (2022)

Plasmid-Based Stat3 siRNA Delivered by Functional Graphene Oxide Suppresses Mouse Malignant Melanoma Cell Growth
por: Yin, Di, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ermgcf1bascgj2qa9flh6kligj